arrow
D

Donald B. Kohn

University of California Los Angeles
H指数:90
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Engineering innate immunity: CRISPR-Cas9 MPO knockout in hematopoietic stem cells abolishes chlorination and PMA-induced NET formation while preserving non-oxidative effector functions

工程天然免疫:CRISPR-Cas9介导的髓过氧化物酶基因敲除在造血干细胞中消除了氯化作用和PMA诱导的NET形成,同时保留了非氧化性效应功能

2026-11-140
OAAI
Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction

CRISPR_SCD001的开发:一种基于CRISPR-Cas9介导修复的自体造血干细胞基因疗法用于镰状细胞病

2026-09-190
OAAI
Investigating Double-Stranded DNA Donors and CRISPR-Cas9 for Universal Correction of Mutations Causing Cystic Fibrosis in Human Airway Cells

研究双链DNA供体和CRISPR-Cas9在人类气道细胞中用于纠正囊性纤维化突变的方法

2026-08-030
OA
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease

镰状细胞病 lentiviral vector 基因治疗的临床结果

2026-05-080
OAAI
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers

Wiskott-Aldrich综合征携带者的临床谱:193名携带者的自我报告调查

2025-12-170
PRE
Prime Editing for p47phox-Deficient Chronic Granulomatous Disease

Gori, J.L.; Haddad, E.; Frangoul, H.; Kohn, D.B.; Morris, E.C.; Martin, B.N.; Deary, B.A.; Nickerson, M.; Scholz, R.L.; Fernandez, I.; et al. 基因组编辑技术用于p47phox缺陷型慢性肉芽肿病。N. Engl. J. Med. 2025. [Google Scholar] [CrossRef] [PubMed]

2025-12-010
PRE
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency

腺苷脱氨酶缺乏症的基因治疗长期安全性与有效性

2025-10-160
PRE
Umbilical Cord Blood Transplantation Provides an Alternative for Patients with Chronic Granulomatous Disease Lacking HLA-Matched Donors: a PIDTC Report

脐带血移植为缺乏HLA匹配供体的慢性肉芽肿病患者提供了替代方案:一份PIDTC报告

2025-10-020
PRE
Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells

慢病毒载体用于造血干细胞基因治疗,可恢复α-地中海贫血红细胞中的α-球蛋白表达

2025-09-170
OAAI
Enhancing pediatric access to cell and gene therapies

提高儿科获得细胞和基因疗法的机会

2024-06-172
PRE
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
2024-05-149
OAAI